In 1994, Marc Wilkins developed the concept of the proteome and coined the term. In 1997 he co-wrote and co-edited the first book on proteomics (4,000+ copies sold). This, and a series of other seminal works, substantially contributed to the establishment of the proteome and of proteome research. Proteomics is the most widely adopted of the new -omics, is now included in biochemistry textbooks and the undergraduate curriculum.
Marc has published >100 peer-reviewed research papers, review papers and book chapters and has edited 2 books. Marc's research has tackled many of the key issues in proteomics. A particular strength has been the capacity to combine large-scale analytical techniques with complex bioinformatics to open new avenues for biological investigation. Current research interests are (i) the role of protein methylation in the proteome (ii) the dynamics of protein interaction networks and (iii) the analysis of next-generation sequencing data.
Marc directs two centres at UNSW: the NSW Systems Biology Initiative (http://www.systemsbiology.org.au/) and the Ramaciotti Centre for Gene Function Analysis (http://www.ramaciotti.unsw.edu.au). These centres are funded by NCRIS, EIF Super Science, ARC LIEF and the NSW State Government Science Leveraging Fund.
Marc co-founded Proteome Systems Pty Ltd in 1999. Recently renamed to Tyrian Diagnostics, this proteomic diagnostics company is listed on the Australian Securities Exchange and has developed technology for rapid point-of-care diagnostic testing . Marc is also a co-founder and non-executive Director of Regeneus Pty Ltd, a privately held regenerative medicine company which uses autologous adult stem cells to treat a range of musculoskeletal disorders.